In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show ...

The drugmaker Gilead Sciences on Wednesday announced a plan to allow six generic pharmaceutical companies in Asia and North ...

This partnership is poised to revolutionize clinical insights and decision-making for the pharma industry with the aim of ...

A small clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature of long COVID.

Phase 2 trial is an adaptive designed randomized study comparing NGC-Cap to monotherapy capecitabineResults from this Phase 2 trial will evaluate ...

Monogram has obtained FDA clearance for mPress implants and applied for 510 (k) clearance for its robotic products. The Company is required to obtain FDA clearance before it can market its products.

While promising, questions remain about sustained long-term benefits of cardiac myosin inhibitors and their impact on ...

Calviri recently announced the initiation of new vaccine trial that targets early-stage hemangiosarcoma tumors in canines ...

A new study shows that a group parenting intervention significantly reduces male postpartum depression (PPD) in fathers, with over 70% of participants experiencing full remission of symptoms.

In September, the Securities and Exchange Commission brought charges against Cassava Sciences, alleging that the company had ...

A new study reveals that dronabinol, a synthetic form of THC, can reduce agitation in Alzheimer’s patients by 30%.

Psychedelic group therapy can foster deep connection and healing. By sharing experiences, patients find love and support, ...